Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$36.5 - $52.5 $148,737 - $213,937
4,075 New
4,075 $200,000
Q1 2023

Oct 21, 2024

BUY
$24.97 - $34.05 $322,113 - $439,244
12,900 New
12,900 $332,000
Q1 2023

May 03, 2023

SELL
$24.97 - $34.05 $859,492 - $1.17 Million
-34,421 Reduced 72.74%
12,900 $332,000
Q4 2022

Feb 13, 2023

BUY
$21.73 - $28.72 $732,648 - $968,323
33,716 Added 247.82%
47,321 $1.23 Million
Q3 2022

Nov 07, 2022

SELL
$24.1 - $39.66 $662,629 - $1.09 Million
-27,495 Reduced 66.9%
13,605 $388,000
Q2 2022

Aug 09, 2022

BUY
$18.36 - $60.07 $754,596 - $2.47 Million
41,100 New
41,100 $1.01 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.34B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.